这些药物由“临床资料公司”(Clinical DataInc .)制造，是一个5 - HT再摄取抑制剂与5ht1a激动剂的化合物。
The medication, manufactured by Clinical Data Inc., is a combined serotonin reuptake inhibitor and 5ht1a agonist.
为了合成新的化合物，化学家们总是按照古老的做法，把各种反应物放在一起搅拌，再对这样得到的混合物进行加热。
To synthesize new compounds, chemists have followed the time-honored recipe of stirring together the reactants and heating the resulting mixture.
药物化学家们再对筛选出来的化合物结构进行研究，设计出药效提高而没有毒性的化合物，然后进行动物试验及临床试验。
Medicinal chemists would then study the structures of compounds that pass the screen and design compounds that enhance the activity without being toxic. Animal and human trials would follow.
目的探讨化合物N - 2 2 11对大鼠局灶性脑缺血再灌注损伤的保护作用。
Objective Aim To investigate the protective effect of compound N-2211 on cerebral ischemia-reperfusion injury in rats.
目的探讨化合物N - 2 2 11对大鼠局灶性脑缺血再灌注损伤的保护作用。
Objective Aim To investigate the protective effect of compound N-2211 on cerebral ischemia-reperfusion injury in rats.
应用推荐